Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
IFPMA
IFPMA
Activities:
Media
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Global CDMO joins antimicrobial resistance alliance
Recipharm manufactures antibiotics in Sweden, Italy and India so has joined AMR Industry Alliance to get involved in developing solutions to combat resistance
Manufacturing
Stefan Oschmann takes over as President of IFPMA
Pledges to focus on accelerating access to medicines for people in low to middle income countries
Media
Biopharma innovation on the rise in emerging countries, report finds
Significant progress is being made in particular in China
Media
Pharma industry outlines plan to tackle NCDs
Developing countries need more access to treatments
Subscribe now